Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Cisatracurium Besylate NDC 66794-246 by Piramal Critical Care Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
cbi10mg_5ml - CBI10mg 5ml
carton10mg_5ml - carton10mg 5ml
carton200mg_20ml - carton200mg 20ml
cisa-label 200ml-20ml - cisa label 200 ml 20ml
Cisatracurium-Besylate Injection is a paralyzing agent used only for ICU patients for intravenous injection. The injection is sterile, non-pyrogenic, and comes in a single-dose vial of 20 mL. Each mL contains cisatracurium 10 mg equivalent to 13.38 mg cisatracurium besylate and it should be stored at 2° to 8°C (36° to 46°F) in the carton. Facilities must be immediately available for artificial respiration as respiratory arrest may occur. Once removed from the refrigerator, the injection should be used within 21 days even if re-refrigerated, and light should be avoided. The injection is manufactured by Gland Pharma Limited in Hyderabad, India, and is distributed by Piramal Crical Care in Bethlehem, PA, USA (LOT not available).*
image1 - image1
This text appears to represent numerical values related to a percentage. It is not clear what the numbers represent without further context.*
image2 - image2
structure1 - structure1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.